GB8909891D0
(en)
*
|
1989-04-28 |
1989-06-14 |
Riker Laboratories Inc |
Device
|
US6536427B2
(en)
*
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
HU213221B
(en)
*
|
1990-03-02 |
1997-03-28 |
Glaxo Group Ltd |
Inhalation device and medicine packet for device
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
UA26230A
(uk)
*
|
1990-03-02 |
1999-07-19 |
Глексо Груп Лімітед |
Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
PL173275B1
(pl)
*
|
1992-09-11 |
1998-02-27 |
Glaxo Group Ltd |
Urządzenie inhalacyjne
|
SE9203570D0
(sv)
*
|
1992-11-27 |
1992-11-27 |
Astra Ab |
Inhaler for multiple use
|
EP0675742B1
(en)
*
|
1992-12-24 |
1998-03-04 |
Rhone-Poulenc Rorer Limited |
Inhaler devices
|
US5896855A
(en)
*
|
1992-12-24 |
1999-04-27 |
Rhone-Poulenc Rorer Limited |
Multi dose inhaler apparatus
|
GB9326574D0
(en)
*
|
1993-12-31 |
1994-03-02 |
King S College London |
Dry power inhalers
|
JPH07219571A
(ja)
*
|
1994-01-31 |
1995-08-18 |
Yukihiko Takino |
カラオケ曲目表示装置
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
CN1195466C
(zh)
*
|
1994-08-30 |
2005-04-06 |
法玛西亚普强公司 |
眼睛治疗装置
|
GB9417399D0
(en)
|
1994-08-30 |
1994-10-19 |
Scherer Corp R P |
Ocular treatment device
|
DE29501527U1
(de)
*
|
1995-02-01 |
1995-03-30 |
Hugo Kern und Liebers GmbH & Co. Platinen- und Federnfabrik, 78713 Schramberg |
Vorrichtung zur Erzeugung inhalierbarer Wirkstoffpartikel
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
SE9503344D0
(sv)
*
|
1995-09-27 |
1995-09-27 |
Astra Ab |
Inhalation device
|
ES2167987T3
(es)
|
1996-01-03 |
2002-05-16 |
Glaxo Group Ltd |
Dispositivo inhalador.
|
US5871010A
(en)
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
GB9626233D0
(en)
*
|
1996-12-18 |
1997-02-05 |
Chawla Brinda P S |
Medicament packaging and deliveery device
|
SE9700424D0
(sv)
*
|
1997-02-07 |
1997-02-07 |
Astra Ab |
Powder inhaler
|
US6006747A
(en)
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
CA2212430A1
(en)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US5954047A
(en)
*
|
1997-10-17 |
1999-09-21 |
Systemic Pulmonary Development, Ltd. |
Methods and apparatus for delivering aerosolized medication
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
AU2281300A
(en)
*
|
1999-01-22 |
2000-08-07 |
Glaxo Group Limited |
Inhalation device
|
GB9905538D0
(en)
|
1999-03-10 |
1999-05-05 |
Glaxo Group Ltd |
A device
|
US6601729B1
(en)
|
1999-03-26 |
2003-08-05 |
Papp Enterprises, Llc |
Automated portable medication radial dispensing apparatus and method using a carrier tape
|
GB9909354D0
(en)
*
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
GB9909357D0
(en)
*
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US6730066B1
(en)
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9925934D0
(en)
|
1999-11-03 |
1999-12-29 |
Glaxo Group Ltd |
Novel apparatus and process
|
US6679256B2
(en)
*
|
1999-12-17 |
2004-01-20 |
Nektar Therapeutics |
Systems and methods for extracting powders from receptacles
|
US7171965B2
(en)
*
|
2000-02-01 |
2007-02-06 |
Valois S.A.S. |
Breath actuated dry powder inhaler and tape dose strip
|
GB0004456D0
(en)
*
|
2000-02-26 |
2000-04-19 |
Glaxo Group Ltd |
Medicament dispenser
|
DE10011120A1
(de)
*
|
2000-03-09 |
2001-09-13 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
AU2001250901A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Dura Pharmaceuticals, Inc. |
Containers for individual doses of an inhalable pharmaceutical
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
CA2382133C
(en)
*
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
GB0012465D0
(en)
*
|
2000-05-24 |
2000-07-12 |
Glaxo Group Ltd |
Monitoring method
|
GB0013619D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Glaxo Group Ltd |
Sample container
|
GB0014851D0
(en)
*
|
2000-06-16 |
2000-08-09 |
Glaxo Group Ltd |
Novel pharmaceutical formulation
|
GB0015034D0
(en)
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
TWI224513B
(en)
*
|
2000-06-23 |
2004-12-01 |
Norton Healthcare Ltd |
Dose counter for medicament inhaler
|
US7080644B2
(en)
*
|
2000-06-28 |
2006-07-25 |
Microdose Technologies, Inc. |
Packaging and delivery of pharmaceuticals and drugs
|
WO2002005879A1
(en)
|
2000-07-15 |
2002-01-24 |
Glaxo Group Limited |
Medicament dispenser
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
DZ3468A1
(fr)
|
2000-08-05 |
2002-02-14 |
Glaxo Group Ltd |
6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyle) oxy!-11.beta.-hydroxy-16.alpha.-methyle-3-oxo-androst-1,4,-diene-17-acide carbothioique s-fluoromethyle ester utilise comme agent anti inflammatoire
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
WO2002013897A2
(en)
|
2000-08-14 |
2002-02-21 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
AUPR020400A0
(en)
*
|
2000-09-19 |
2000-10-12 |
Glaxo Wellcome Australia Ltd |
Inhalation device
|
GB0026647D0
(en)
*
|
2000-10-31 |
2000-12-13 |
Glaxo Group Ltd |
Medicament dispenser
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
DE10111945B4
(de)
*
|
2001-03-13 |
2006-03-09 |
Alexander Christ |
Kapselspender
|
JP4143413B2
(ja)
|
2001-03-22 |
2008-09-03 |
グラクソ グループ リミテッド |
β2−アドレナリン受容体アゴニストとしてのホルムアニリド誘導体
|
US6766799B2
(en)
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
CN1302007C
(zh)
|
2001-04-30 |
2007-02-28 |
葛兰素集团有限公司 |
具有抗炎性的在17.α位上具有环酯基的雄甾烷的17.β.-硫代羧酸酯衍生物
|
US20030051728A1
(en)
*
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
FI20011317A0
(fi)
*
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Jauheinhalaattori
|
EP1416990A1
(en)
*
|
2001-08-09 |
2004-05-12 |
Glaxo Group Limited |
Inhalation device with a pharmaceutical composition
|
CN103288793B
(zh)
|
2001-09-14 |
2015-09-23 |
葛兰素集团有限公司 |
治疗呼吸疾病的苯乙醇胺衍生物
|
JP2005507881A
(ja)
|
2001-09-17 |
2005-03-24 |
グラクソ グループ リミテッド |
乾燥粉末医薬製剤
|
JP4261351B2
(ja)
|
2001-09-19 |
2009-04-30 |
アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド |
吸入器
|
GB0125135D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0125132D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0125134D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0127989D0
(en)
*
|
2001-11-22 |
2002-01-16 |
Glaxo Group Ltd |
Medicament dispensing system
|
GB0130055D0
(en)
*
|
2001-12-14 |
2002-02-06 |
Technology Innovation Ltd |
Medicament packaging
|
WO2003053411A1
(en)
*
|
2001-12-19 |
2003-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US20070062525A1
(en)
*
|
2002-01-25 |
2007-03-22 |
Bonney Stanley G |
Medicament dispenser
|
GB0217199D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0201677D0
(en)
*
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
US20060187750A1
(en)
*
|
2002-03-01 |
2006-08-24 |
Victor Aldrich |
Rotary blending apparatus and system
|
AU2003209475A1
(en)
*
|
2002-03-07 |
2003-09-16 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
GB0205572D0
(en)
*
|
2002-03-09 |
2002-04-24 |
Chawla Brinda P S |
Medicament delivery and packaging
|
JP2006504446A
(ja)
*
|
2002-03-26 |
2006-02-09 |
グラクソ グループ リミテッド |
ラミネート・アセンブリーの形成方法、およびそれにより形成される製品
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
US20030235538A1
(en)
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
WO2003091204A1
(en)
|
2002-04-25 |
2003-11-06 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
US7429127B2
(en)
*
|
2002-04-25 |
2008-09-30 |
Glaxo Group Limited |
Magnetoacoustic sensor system and associated method for sensing environmental conditions
|
GB0209526D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0209528D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
JP2005526261A
(ja)
*
|
2002-05-15 |
2005-09-02 |
グラクソ グループ リミテッド |
医薬包装内の温度および水分プロファイルを測定するための微小電気機械システムおよび方法
|
GB0216831D0
(en)
*
|
2002-07-19 |
2002-08-28 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
JP2005533581A
(ja)
|
2002-07-25 |
2005-11-10 |
グラクソ グループ リミテッド |
薬剤ディスペンサ
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AU2003254590A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Glaxo Group Limited |
Medicament dispenser
|
US20070139442A1
(en)
*
|
2002-09-13 |
2007-06-21 |
Robinson Karl E |
Coated blending system
|
GB0221493D0
(en)
*
|
2002-09-17 |
2002-10-23 |
Glaxo Group Ltd |
Method for loading a medicament dispenser with a medicament carrier
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
US20060205790A1
(en)
*
|
2002-10-22 |
2006-09-14 |
Coe Diane M |
Medicinal arylethanolamine compounds
|
WO2004037773A1
(en)
|
2002-10-28 |
2004-05-06 |
Glaxo Group Limited |
Phenethanolamine derivative for the treatment of respiratory diseases
|
JP2006511297A
(ja)
*
|
2002-12-18 |
2006-04-06 |
グラクソ グループ リミテッド |
ベント型マウスピースを有する投薬システム
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0303870D0
(en)
*
|
2003-02-20 |
2003-03-26 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
US7562769B2
(en)
*
|
2003-03-15 |
2009-07-21 |
Brintech International Limited |
Formulation and presentation of medicaments
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
SE527069C2
(sv)
*
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
TW200519108A
(en)
|
2003-07-17 |
2005-06-16 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
GB0317374D0
(en)
*
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
WO2005037280A1
(en)
|
2003-10-14 |
2005-04-28 |
Glaxo Group Limited |
Muscarinic acetycholine receptor antagonists
|
CA2542636A1
(en)
|
2003-10-17 |
2005-04-28 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists field of the invention
|
GB2407042B
(en)
*
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
US20070053843A1
(en)
*
|
2003-10-28 |
2007-03-08 |
Dawson Michelle L |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
AU2004294889B2
(en)
*
|
2003-12-03 |
2010-08-26 |
Boehringer Ingelheim International Gmbh |
Medical product containing tiotropium
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
US7631812B2
(en)
*
|
2003-12-10 |
2009-12-15 |
Williams Troy P |
Foldable transaction card systems
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
WO2005076872A2
(en)
*
|
2004-02-06 |
2005-08-25 |
Microdose Technologies, Inc. |
A blister pack for use with an inhalation device
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
BRPI0507714B8
(pt)
*
|
2004-02-16 |
2021-07-27 |
Glaxo Group Ltd |
contador de dose para uso com um dispensador de medicamento, e, dispensador de medicamento
|
JP2007528420A
(ja)
*
|
2004-03-11 |
2007-10-11 |
グラクソ グループ リミテッド |
新規m3ムスカリン性アセチルコリン受容体アンタゴニスト
|
JP2007529513A
(ja)
|
2004-03-17 |
2007-10-25 |
グラクソ グループ リミテッド |
M3ムスカリン性アセチルコリン受容体アンタゴニスト
|
EP1730104A1
(en)
|
2004-04-02 |
2006-12-13 |
Glaxo Group Limited |
Chemical process and new crystalline form
|
US7828147B2
(en)
*
|
2004-04-24 |
2010-11-09 |
Inrange Systems, Inc. |
Multi-layer medication carrier
|
US8019471B2
(en)
*
|
2004-04-24 |
2011-09-13 |
Inrange Systems, Inc. |
Integrated, non-sequential, remote medication management and compliance system
|
UY28871A1
(es)
|
2004-04-27 |
2005-11-30 |
Glaxo Group Ltd |
Antagonistas del receptor de acetilcolina muscarinico
|
JP2007537261A
(ja)
|
2004-05-13 |
2007-12-20 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
PT1891974E
(pt)
|
2004-05-31 |
2010-09-27 |
Almirall Sa |
Combinações que compreendem agentes anti-muscarínicos e inibidores de pde4
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
SE0401654D0
(sv)
*
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
A support structure for a medicament
|
FR2872798B1
(fr)
*
|
2004-07-09 |
2007-10-05 |
Valois Sas |
Ensemble de blisters pour dispositif d'inhalation
|
GB0418278D0
(en)
*
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
JP4908419B2
(ja)
*
|
2004-10-06 |
2012-04-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ディスペンサ、貯蔵装置及び粉末の小出し方法
|
EP1812778A2
(en)
*
|
2004-11-12 |
2007-08-01 |
Glaxo Group Limited |
Sensor system with acoustic transducer
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
WO2006074897A1
(en)
*
|
2005-01-11 |
2006-07-20 |
Glaxo Group Limited |
Cinnamate salts of a beta-2 adrenergic agonist
|
FR2881117B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881119B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881118B1
(fr)
*
|
2005-01-25 |
2007-04-20 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881111B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
NZ556709A
(en)
|
2005-02-10 |
2009-09-25 |
Glaxo Group Ltd |
Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
|
US20090029901A1
(en)
*
|
2005-02-10 |
2009-01-29 |
Marian Wood-Kaczmar |
Process for Crystallizing Lactose Particles for Use in Pharmaceutical Formulations
|
PE20100741A1
(es)
|
2005-03-25 |
2010-11-25 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2(1H)-ONA COMO INHIBIDORES DE QUINASA p38
|
TWI389690B
(zh)
|
2005-03-25 |
2013-03-21 |
Glaxo Group Ltd |
新穎化合物(一)
|
WO2006117353A1
(en)
*
|
2005-05-04 |
2006-11-09 |
Boehringer Ingelheim International Gmbh |
Inhalation device containing plural doses of a pharmaceutical composition
|
GB0509952D0
(en)
|
2005-05-16 |
2005-06-22 |
Glaxo Group Ltd |
Fault indicator
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
DE102005035705A1
(de)
*
|
2005-07-27 |
2007-02-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Arzneimittelblister
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1937230A4
(en)
*
|
2005-08-02 |
2009-08-26 |
Glaxo Group Ltd |
M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS
|
JP2009503099A
(ja)
*
|
2005-08-02 |
2009-01-29 |
グラクソ グループ リミテッド |
M3ムスカリン性アセチルコリン受容体アンタゴニスト
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
JP2009504768A
(ja)
|
2005-08-18 |
2009-02-05 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
US20070068837A1
(en)
*
|
2005-09-29 |
2007-03-29 |
D Angelis Bruno S |
Wound dressing dispenser
|
GB0521563D0
(en)
|
2005-10-21 |
2005-11-30 |
Glaxo Group Ltd |
Novel compounds
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
US7987845B2
(en)
|
2006-01-31 |
2011-08-02 |
Oriel Therapeutics, Inc. |
Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
CA2644679C
(en)
*
|
2006-03-03 |
2013-12-03 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
GB0605150D0
(en)
*
|
2006-03-14 |
2006-04-26 |
Glaxo Group Ltd |
Counter For Use With A Medicament Dispenser
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
EP1844809A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator
|
KR20090003349A
(ko)
|
2006-04-20 |
2009-01-09 |
글락소 그룹 리미티드 |
화합물
|
GR1005620B
(el)
*
|
2006-05-09 |
2007-09-03 |
|
Βελτιωση συσκευης εισπνοων ξηρης σκονης
|
GR1005668B
(el)
*
|
2006-05-09 |
2007-10-02 |
|
Συσκευη εισπνοων ξηρης σκονης για την ταυτοχρονη χορηγηση περισσοτερων απο μιας φαρμακευτικων ουσιων
|
DE102006023662A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
US9457161B2
(en)
|
2006-05-18 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
FR2904229B1
(fr)
*
|
2006-07-25 |
2008-10-10 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
US20090325952A1
(en)
|
2006-08-01 |
2009-12-31 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
|
EP2077882A2
(en)
|
2006-10-25 |
2009-07-15 |
Nektar Therapeutics |
Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
|
GB0622827D0
(en)
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
WO2008081132A2
(fr)
*
|
2006-12-11 |
2008-07-10 |
Valois Sas |
Dispositif de distribution de produit fluide
|
FR2909643B1
(fr)
*
|
2006-12-11 |
2011-03-04 |
Valois Sas |
Dispositif de distribution de produit fluide
|
US20080163610A1
(en)
*
|
2007-01-05 |
2008-07-10 |
Matthew Thomas Baird |
Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
US8616199B2
(en)
|
2007-03-16 |
2013-12-31 |
Canon Kabushiki Kaisha |
Inhaler and ejection head unit attachable to the inhaler
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
JP5198801B2
(ja)
*
|
2007-05-30 |
2013-05-15 |
株式会社吉野工業所 |
吸引式投薬器
|
US8496002B2
(en)
*
|
2007-06-12 |
2013-07-30 |
Civitas Therapeutics, Inc. |
Powder inhaler devices
|
EP2011538B1
(en)
|
2007-07-06 |
2016-02-17 |
Vectura Delivery Devices Limited |
Inhaler
|
EP2162174A1
(en)
*
|
2007-07-06 |
2010-03-17 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2011536A1
(en)
*
|
2007-07-06 |
2009-01-07 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhaler
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
RU2484852C2
(ru)
|
2007-12-20 |
2013-06-20 |
Астразенека Аб |
Устройство и способ дезагрегации порошкообразного средства 854
|
JP5465185B2
(ja)
*
|
2008-01-23 |
2014-04-09 |
アストラゼネカ・アクチエボラーグ |
ユーザーに示標を提示する表示部を有する薬剤収容投薬器
|
EP2082758A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2082759A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2082764A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2096105A1
(en)
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2108641A1
(en)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
EP2113503A1
(en)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
US8517009B2
(en)
|
2008-07-13 |
2013-08-27 |
Map Pharmaceuticals, Inc. |
Methods and apparatus for delivering aerosolized medication
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
US8887722B2
(en)
*
|
2008-09-26 |
2014-11-18 |
Oriel Therapeutics, Inc. |
Inhaler mechanisms with radially biased piercers and related methods
|
EP2346556B1
(en)
|
2008-09-26 |
2014-11-05 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with dual piercing members and related devices and methods
|
CA2732842C
(en)
*
|
2008-09-26 |
2018-01-09 |
Oriel Therapeutics, Inc. |
Inhalers with airway disks having discrete airway channels and related disks and methods
|
US9050427B2
(en)
*
|
2008-09-30 |
2015-06-09 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
EP2328645B1
(en)
*
|
2008-10-01 |
2015-11-11 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with rotating piercing mechanisms and related devices and methods
|
MX2011003799A
(es)
*
|
2008-10-08 |
2011-06-16 |
Astrazeneca Ab |
Inhalador con medio indicador audible.
|
GB201020130D0
(en)
*
|
2010-11-26 |
2011-01-12 |
Vectura Delivery Devices Ltd |
Inhaler
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
EP2198908A1
(en)
*
|
2008-12-19 |
2010-06-23 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
BRPI1006162A2
(pt)
|
2009-01-13 |
2019-09-24 |
Glaxo Group Ltd |
"composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
|
NZ574666A
(en)
*
|
2009-02-05 |
2009-04-30 |
Nexus6 Ltd |
A medicament inhaler holder that uses optical means to count and display the number of doses used
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
EP2221055A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
|
EP2221297A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
|
WO2010097115A1
(en)
|
2009-02-26 |
2010-09-02 |
Glaxo Group Limited |
Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol
|
EP2226323A1
(en)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
|
EP2228368A1
(en)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
WO2010122089A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
N-pyrazolyl carboxamides as crac channel inhibitors
|
EP2421834A1
(en)
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
DE202009006141U1
(de)
|
2009-04-25 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Inhalator
|
CN102438578A
(zh)
|
2009-05-07 |
2012-05-02 |
基伊埃制药系统有限公司 |
药片生产模块和用于连续生产药片的方法
|
CN102573969B
(zh)
|
2009-05-18 |
2014-05-21 |
诺顿·希尔思凯尔有限公司 |
干燥粉末吸入器
|
CN102481423B
(zh)
|
2009-05-18 |
2015-11-25 |
诺顿·希尔思凯尔有限公司 |
干燥粉末吸入器
|
WO2010135253A2
(en)
|
2009-05-18 |
2010-11-25 |
3M Innovative Properties Company |
Dry powder inhaler dose counters
|
WO2010135340A2
(en)
|
2009-05-18 |
2010-11-25 |
3M Innovative Properties Company |
Dry powder inhalers
|
DK2432532T3
(da)
|
2009-05-18 |
2014-10-06 |
Norton Healthcare Ltd |
Tørpulverinhalator
|
US8763606B2
(en)
*
|
2009-05-21 |
2014-07-01 |
Microdose Therapeutx, Inc. |
Rotary cassette system for dry powder inhaler
|
US8985101B2
(en)
|
2009-05-21 |
2015-03-24 |
Microdose Therapeutx, Inc. |
Method and device for clamping a blister within a dry powder inhaler
|
EP2443134A2
(en)
|
2009-06-16 |
2012-04-25 |
Schering Corporation |
NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
|
BRPI1015579A2
(pt)
|
2009-07-01 |
2019-09-24 |
Astrazeneca Ab |
distribuidor e método para suspender pó em um fluxo de ar
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
EP2955524A3
(en)
|
2009-11-05 |
2016-03-23 |
GlaxoSmithKline LLC |
Novel process
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
EP2496582B1
(en)
|
2009-11-05 |
2016-01-27 |
GlaxoSmithKline LLC |
Benzodiazepine bromodomain inhibitor
|
PL2722334T3
(pl)
|
2009-11-05 |
2016-06-30 |
Glaxosmithkline Llc |
Benzodiazepinowy inhibitor bromodomen
|
EP2322176A1
(en)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
|
CA2779488A1
(en)
|
2009-11-12 |
2011-05-19 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
TR200909791A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
CN102665807A
(zh)
|
2010-01-05 |
2012-09-12 |
微剂量治疗技术公司 |
吸入设备和方法
|
US9046403B2
(en)
*
|
2010-02-01 |
2015-06-02 |
Mallinckrodt Llc |
Systems and methods for managing use of a medicament
|
US8490795B2
(en)
|
2010-02-01 |
2013-07-23 |
Mallinckrodt Llc |
Container and method for facilitating disposal of unused pharmaceutical product
|
EP2566546B1
(en)
*
|
2010-04-13 |
2016-03-30 |
Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. |
Dry powder inhaler mouthpiece button
|
EP2380890A1
(en)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
EP2386555A1
(en)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
|
EP2394998A1
(en)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
|
FR2961186B1
(fr)
*
|
2010-06-11 |
2012-07-13 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
JP5844358B2
(ja)
|
2010-06-22 |
2016-01-13 |
グラクソスミスクライン エルエルシー |
ベンゾトリアゾロジアゼピン化合物を含むブロモドメイン阻害剤
|
FR2962345B1
(fr)
|
2010-07-09 |
2013-06-21 |
Valois Sas |
Inhalateur unidose de poudre seche pour blister pelable.
|
US20140000601A1
(en)
|
2010-07-21 |
2014-01-02 |
Astrazeneca Ab |
Inhaler
|
WO2012025473A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Cc.chemokine receptor 4 antagonists
|
WO2012025474A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Indazole compounds
|
WO2012028662A1
(en)
|
2010-08-31 |
2012-03-08 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
EP2611423B2
(en)
|
2010-08-31 |
2022-09-21 |
GlaxoSmithKline Intellectual Property Development Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
EP2441755A1
(en)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
|
EP2630126B1
(en)
|
2010-10-21 |
2015-01-07 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, immune and inflammatory conditions
|
US9149462B2
(en)
|
2010-10-21 |
2015-10-06 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
SG190793A1
(en)
|
2010-11-11 |
2013-07-31 |
Agency Science Tech & Res |
Targeting metabolic enzymes in human cancer
|
EP2457900A1
(en)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
New pyrazole derivatives having CRTh2 antagonistic behaviour
|
EP2463289A1
(en)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
JP6050758B2
(ja)
|
2010-12-07 |
2016-12-21 |
レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. |
乾燥粉末吸入器及びその作動方法
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
US8834411B2
(en)
|
2011-04-06 |
2014-09-16 |
Mystic Pharmaceuticals, Inc. |
Medical devices for dispensing powders
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
EP2526945A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
New CRTH2 Antagonists
|
EP2527344A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
|
JP2014518894A
(ja)
|
2011-06-08 |
2014-08-07 |
グラクソ グループ リミテッド |
ウメクリジニウムを含む乾燥粉末インヘラー組成物
|
US20140113888A1
(en)
|
2011-06-08 |
2014-04-24 |
Glaxo Group Limited |
Novel Combination of Therapeutic Agents
|
EP2548876A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists
|
EP2548863A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists.
|
EP2554544A1
(en)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1h)-one derivatives as jak inhibitors
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
EP2578570A1
(en)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
|
EP2592078A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
EP2592077A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
WO2013114374A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
GB2499597A
(en)
*
|
2012-02-21 |
2013-08-28 |
Innovata Biomed Ltd |
Dry powder inhaler with stepped rotation of metering member
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
EP2647627A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
|
DE102012104850A1
(de)
|
2012-04-05 |
2013-10-10 |
Alfred Von Schuckmann |
Vorrichtung zur portionierten Ausgabe von Medikamenten
|
ES2814336T3
(es)
|
2012-04-13 |
2021-03-26 |
Glaxosmithkline Ip Dev Ltd |
Partículas de agregado
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
TWI593678B
(zh)
|
2012-04-27 |
2017-08-01 |
葛蘭素集團有限公司 |
作為類視色素相關孤兒受體γ(RORγ)調節劑之化合物、其醫藥組合物及用途
|
EP2662105B1
(de)
|
2012-05-09 |
2017-01-18 |
Boehringer Ingelheim International GmbH |
Zerstäuber
|
FR2990872B1
(fr)
*
|
2012-05-24 |
2015-05-15 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
EP2666465A1
(en)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Novel dosage and formulation
|
GB2502350A
(en)
|
2012-05-25 |
2013-11-27 |
Vectura Delivery Devices Ltd |
Inhaler having means to control the force applied to an actuating lever
|
EA201492044A1
(ru)
*
|
2012-05-25 |
2015-05-29 |
Арвен Айлак Санайи Ве Тиджарет А.С. |
Ингалятор, содержащий внутренний корпус, имеющий канал для воздуха
|
WO2013176639A1
(en)
*
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Inhaler device with an improved blister advancement mechanism
|
EP2668941A1
(en)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Novel dosage form and formulation of abediterol
|
EP2866868A2
(en)
|
2012-07-05 |
2015-05-06 |
Glaxo Group Limited |
Inhaler device
|
WO2014060431A1
(en)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
MY170802A
(en)
|
2012-11-28 |
2019-08-28 |
Intercept Pharmaceuticals Inc |
Treatment of pulmonary disease
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
JP5350530B1
(ja)
*
|
2012-12-07 |
2013-11-27 |
ニップファーマ株式会社 |
薬剤吸入デバイス
|
CN105142673B8
(zh)
|
2012-12-18 |
2018-02-16 |
阿尔米雷尔有限公司 |
具有β2肾上腺素能激动剂及M3毒蕈碱拮抗剂活性的新型环己基和奎宁环基氨基甲酸酯衍生物
|
TW201446767A
(zh)
|
2013-02-15 |
2014-12-16 |
Almirall Sa |
作為磷脂肌醇3-激酶抑製劑之吡咯並三嗪衍生物
|
RU2655727C9
(ru)
|
2013-03-14 |
2018-07-06 |
ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед |
Фуропиридины в качестве ингибиторов бромодоменов
|
PE20151596A1
(es)
|
2013-03-14 |
2015-11-24 |
Glaxosmithkline Intellectual Property N 2 Ltd |
Derivados de 1-acil-4-amino-1,2,3,4-tetrahidroquinolina 2,3-disustituidos y su uso como inhibidores del bromodominio
|
GB201305668D0
(en)
|
2013-03-28 |
2013-05-15 |
Glaxosmithkline Ip Dev Ltd |
Avs6 Integrin Antagonists
|
JP5985434B2
(ja)
*
|
2013-04-25 |
2016-09-06 |
株式会社吉野工業所 |
吸引器具
|
JP6105373B2
(ja)
*
|
2013-04-25 |
2017-03-29 |
株式会社吉野工業所 |
吸引器具
|
RU2544801C2
(ru)
*
|
2013-06-11 |
2015-03-20 |
Открытое Акционерное Общество "Фармацевтическая Фабрика Санкт-Петербурга" |
Порошковый ингалятор
|
EP2848615A1
(en)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
New pyrazole derivatives as CRAC channel modulators
|
USD737425S1
(en)
|
2013-07-09 |
2015-08-25 |
Celon Pharma S.A. |
Inhaler
|
USD759163S1
(en)
|
2013-07-30 |
2016-06-14 |
Celon Pharma S.A. |
Label for an inhaler
|
USD746378S1
(en)
|
2013-07-30 |
2015-12-29 |
Celon Pharma S.A. |
Label for an inhaler
|
CN103624401B
(zh)
*
|
2013-08-20 |
2016-03-02 |
南京理工大学 |
立式定量控制的自动爆炸复合炸药铺放装置
|
WO2015091285A1
(en)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Dosage formulation comprising salmeterol and fluticasone propionate
|
EA034279B1
(ru)
|
2013-12-23 |
2020-01-24 |
Гленмарк Фармасьютикалс Лтд |
Ингалятор сухого порошка
|
MX2016014859A
(es)
|
2014-05-12 |
2017-06-27 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Composiciones farmaceuticas que comprenden danirixina para tratar enfermedades infecciosas.
|
ES2959699T3
(es)
|
2014-05-28 |
2024-02-27 |
Glaxosmithkline Ip Dev Ltd |
Furoato de fluticasona en el tratamiento de la EPOC
|
EP2957553A1
(en)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations of vilanterol
|
EP2957552B1
(en)
|
2014-06-16 |
2020-01-22 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Vilanterol formulations
|
TR201407010A2
(tr)
|
2014-06-16 |
2015-12-21 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Vilanterol formülasyonları.
|
MA39288A
(fr)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret As |
Formulations pharmaceutiques comprenant du vilanterol
|
WO2016057693A1
(en)
|
2014-10-10 |
2016-04-14 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
US9550032B2
(en)
*
|
2014-10-12 |
2017-01-24 |
Kendra Baldwin |
Wearable wrist inhaler
|
EP3212212B1
(en)
|
2014-10-31 |
2020-09-23 |
Monash University |
Powder formulation
|
CA2972826C
(en)
|
2015-01-14 |
2023-09-12 |
Respira Therapeutics, Inc. |
Powder dispersion methods and devices
|
GB201503720D0
(en)
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
TW201643179A
(zh)
|
2015-03-11 |
2016-12-16 |
葛蘭素史克智慧財產發展有限公司 |
Tslp結合蛋白
|
USD767114S1
(en)
|
2015-03-18 |
2016-09-20 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
USD769439S1
(en)
|
2015-03-18 |
2016-10-18 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
GB201504689D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
WO2016161830A1
(zh)
*
|
2015-04-09 |
2016-10-13 |
正大天晴药业集团股份有限公司 |
药物释放带
|
CN106139335B
(zh)
*
|
2015-04-09 |
2022-12-16 |
正大天晴药业集团股份有限公司 |
一种药粉释放装置
|
TWI597079B
(zh)
*
|
2015-04-10 |
2017-09-01 |
微劑量醫療公司 |
泡殼帶進給機構
|
WO2016170009A1
(en)
|
2015-04-21 |
2016-10-27 |
Almirall, S.A. |
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
|
AU364719S
(en)
|
2015-05-20 |
2015-10-14 |
Korea United Pharm Inc |
Medicine inhaler
|
DK3782996T3
(da)
|
2015-06-15 |
2024-04-22 |
Glaxosmithkline Ip Dev Ltd |
NRF2-regulatorer
|
KR20180017038A
(ko)
|
2015-06-15 |
2018-02-20 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Nrf2 조절제
|
MA52032A
(fr)
|
2015-06-15 |
2021-01-20 |
Astex Therapeutics Ltd |
Régulateurs de nrf2
|
WO2016202800A1
(en)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
CN107614037B
(zh)
*
|
2015-07-29 |
2021-09-03 |
正大天晴药业集团股份有限公司 |
药物释放带
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
RU2018112312A
(ru)
|
2015-09-22 |
2019-10-23 |
ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед |
Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена
|
EP3371167A1
(en)
|
2015-10-06 |
2018-09-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as nrf2 regulators
|
US10364256B2
(en)
|
2015-10-06 |
2019-07-30 |
Glaxosmithkline Intellectual Property Development Limited |
Biaryl pyrazoles as NRF2 regulators
|
EP3377045A1
(en)
|
2015-11-18 |
2018-09-26 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions of ribavirin
|
GB201604680D0
(en)
|
2016-03-21 |
2016-05-04 |
Glaxosmithkline Ip Dev Ltd |
Chemical Compounds
|
AU2017245641A1
(en)
|
2016-04-07 |
2018-09-13 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pyridyl derivatives as bromodomain inhibitors
|
ES2785173T3
(es)
|
2016-04-07 |
2020-10-06 |
Glaxosmithkline Ip No 2 Ltd |
Benzo[b]furanos como inhibidores de bromodominio
|
WO2017176291A1
(en)
*
|
2016-04-08 |
2017-10-12 |
Kendra Baldwin T |
Wearable wrist inhaler
|
US10844015B2
(en)
|
2016-05-24 |
2020-11-24 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pyridine dicarboxamide derivatives as bromodomain inhibitors
|
GB201614940D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
GB201614934D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
GB201614939D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
WO2018055527A1
(en)
|
2016-09-20 |
2018-03-29 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Trpv4 antagonists
|
WO2018055526A1
(en)
|
2016-09-20 |
2018-03-29 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Trpv4 antagonists
|
CN109045427B
(zh)
*
|
2016-10-03 |
2021-06-25 |
捷普科技(上海)有限公司 |
药剂分配器
|
US20190307975A1
(en)
|
2016-11-21 |
2019-10-10 |
Lupin Inc. |
Medicament dispenser
|
WO2018104766A1
(en)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
3-(2,3-dihydro-1h-inden-5-yl)propanoic acid derivatives and their use as nrf2 regulators
|
JP2020500919A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしての3−カルボン酸ピロール
|
JP2020500918A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのn−アリールピラゾール
|
EP3555068B1
(en)
|
2016-12-14 |
2020-12-02 |
GlaxoSmithKline Intellectual Property Development Limited |
3-oxo-1,4-diazepinyle compounds as nrf2 activators
|
WO2018109643A1
(en)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as nrf2 acti
|
JP2020502136A
(ja)
|
2016-12-14 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのビスアリールアミド
|
RU2019121673A
(ru)
|
2016-12-15 |
2021-01-15 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Активаторы nrf2
|
US11059816B2
(en)
|
2016-12-15 |
2021-07-13 |
Glaxosmithkline Intellectual Property Development Limited |
Ether linked triazoles as NRF2 activators
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
GB201703282D0
(en)
|
2017-03-01 |
2017-04-12 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
CN108622469B
(zh)
*
|
2017-03-24 |
2023-08-15 |
李和伟 |
一种独立包装的履带式给药器
|
BR112019020209A2
(pt)
|
2017-03-31 |
2020-06-02 |
Glaxosmithkline Intellectual Property Development Limited |
Composição imunogênica, uso de uma composição imunogênica, método de tratamento ou prevenção de uma recorrência de uma exacerbação aguda de doença pulmonar obstrutiva crônica, e, terapia de combinação.
|
US11014941B2
(en)
|
2017-04-24 |
2021-05-25 |
Cocrystal Pharma, Inc. |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
AU2018308199B2
(en)
|
2017-07-25 |
2023-08-31 |
Adherium (Nz) Limited |
Adherence monitoring method and device
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Nrf2路徑的新穎化合物
|
GB201716369D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
GB201716392D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
WO2019116230A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
MX2020007521A
(es)
|
2018-01-17 |
2022-12-05 |
Glaxosmithkline Ip Dev Ltd |
Inhibidores de pi4kiii.
|
CN110237373B
(zh)
*
|
2018-03-08 |
2023-06-02 |
润生药业有限公司 |
一种生产用于联合用药的药物载体的装置及方法
|
WO2019195711A1
(en)
|
2018-04-06 |
2019-10-10 |
Lupin Inc. |
Medicament dispenser
|
EP3796906A1
(en)
|
2018-05-23 |
2021-03-31 |
GlaxoSmithKline Intellectual Property Management Limited |
Indanes as nrf2 activators
|
EP3829719A1
(en)
|
2018-07-27 |
2021-06-09 |
Cocrystal Pharma, Inc. |
Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
GB201814167D0
(en)
|
2018-08-31 |
2018-10-17 |
Glaxosmithkline Ip No 2 Ltd |
Compounds
|
AU2019339644B2
(en)
|
2018-09-10 |
2021-11-11 |
Cipla Limited |
Single blister-strip based dispenser
|
TWI844564B
(zh)
|
2018-09-10 |
2024-06-11 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
EP3866778B1
(en)
|
2018-10-17 |
2022-11-30 |
Cocrystal Pharma, Inc. |
Combinations of inhibitors of influenza virus replication
|
CN113164612A
(zh)
|
2018-11-13 |
2021-07-23 |
共晶制药公司 |
流感治疗剂的配制物
|
US20220048897A1
(en)
|
2018-11-26 |
2022-02-17 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
CN114072136A
(zh)
|
2019-04-29 |
2022-02-18 |
英斯梅德股份有限公司 |
曲前列素前药的干粉组合物及其使用方法
|
EP3750528A1
(en)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Compositions for treating dystrophies and myotonia
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
WO2021175983A1
(en)
|
2020-03-06 |
2021-09-10 |
Vectura Delivery Devices Limited |
Process for manufacturing a blister strip for a dry powder inhaler
|
WO2021188620A1
(en)
|
2020-03-17 |
2021-09-23 |
Cocrystal Pharma Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
WO2021195353A1
(en)
|
2020-03-25 |
2021-09-30 |
Lupin Inc. |
Multi-carrier medicament dispensers
|
US20230159453A1
(en)
|
2020-04-10 |
2023-05-25 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
WO2021216547A1
(en)
|
2020-04-20 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
EP4061457A1
(en)
|
2020-06-15 |
2022-09-28 |
Norton (Waterford) Limited |
Blister pack and inhaler comprising the same
|
PL244221B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
PL244222B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
WO2022175423A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition, use and methods
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
CN118103351A
(zh)
|
2021-08-03 |
2024-05-28 |
共晶制药公司 |
冠状病毒抑制剂
|
FI4188491T3
(fi)
|
2021-08-13 |
2024-06-07 |
Norton Waterford Ltd |
Kuivajauhelääkeinhalaattori
|
GB202111658D0
(en)
|
2021-08-13 |
2021-09-29 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
GB202113921D0
(en)
|
2021-09-29 |
2021-11-10 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
EP4221793A1
(en)
|
2021-09-29 |
2023-08-09 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
WO2023052477A1
(en)
|
2021-09-29 |
2023-04-06 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
CN114178071B
(zh)
*
|
2021-12-10 |
2022-09-09 |
杭州博乐工业设计股份有限公司 |
一种可更换储液设备的喷雾器
|
WO2023150747A1
(en)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Dry powder compositions of bedaquiline and salts and methods of use thereof
|
GB2618145A
(en)
*
|
2022-04-29 |
2023-11-01 |
Merxin Ltd |
Manifold
|